Genetic susceptibility to tuberculosis: From monogenic to polygenic inheritance

Sepsis

Volumn 4, Issue 3, 2001, Pages 237-246

  Alcaïs, Alexandre ^a   Remus, Natascha ^a   Abel, Laurent ^a   Casanova, Jean Laurent ^a  

^a IMAGINE INSTITUTE   (France)

Author keywords

HLA; Interferon gamma; Interleukin 1; Interleukin 12; Mannose binding protein; NRAMPI; Vitamin D receptor

Indexed keywords

DISEASE ASSOCIATION; DISEASE COURSE; EPIDEMIOLOGICAL DATA; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; MORTALITY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS;

EID: 0035652665     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012917124511     Document Type: Review

References (100)

1. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
2. Is the development of a new tuberculosis vaccine possible?
3. The evolving relation between humans and Mycobacterium tuberculosis
4. Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering?
5. The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future
6. Tuberculosis in twins: A re-analysis of the Prophit survey
7. Twin studies on genetic variations in resistance to tuberculosis
8. Twin studies on the significance of genetic factors in tuberculosis
9. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA
10. Association of pulmonary tuberculosis and HLA in south India
11. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: Relevance to chemotherapy and disease severity
12. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in South India
13. HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions
14. Immunogenetic analysis of human tuberculosis
15. HLA phenotype frequencies in pulmonary tuberculosis
16. No association or linkage with HLA-DR or -DQ genes in south Indians with pulmonary tuberculosis
17. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLADR types
18. The HLA dictionary 1999: A summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens
19. Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians
20. Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: Molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients
21. Association of an HLA-DQ allele with clinical tuberculosis
22. Immunogenetics of leishmanial and mycobacterial infections: The Belem family study
23. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy
24. Transporter associated with antigen-processing (TAP) genes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis
25. Highly informative typing of the human TNF locus using six adjacent polymorphic markers
26. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression
27. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene
28. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
29. 3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans
30. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations
31. Dual role of mannan-binding protein in infections: Another case of heterosis?
32. Mannose-binding protein B allele confers protection against tuberculous meningitis
33. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans
34. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene
35. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study
36. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts
37. Nonspecific and immune-specific up-regulation of cytokines in rabbit dermal tuberculous (BCG) lesions
38. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1 beta on tuberculosis
39. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
40. Genetic susceptibility to tuberculosis in Africans: A genome-wide scan
41. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family
42. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee
43. Tuberculosis and immunodeficiency-of mice and men
44. Idiopathic disseminated bacillus Calmette-Guerin infection: A French national retrospective study
45. Immunological conditions of children with BCG disseminated infection
46. Disseminated bacillus Calmette-Guerin infections in patients with primary immunodeficiencies
47. Clinical presentation of Bacillus Calmette-Guerin infections in patients with immunodeficiency syndromes
48. Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency
49. Disseminated BCG-osteomyelitis in congenital immunodeficiency
50. Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants
51. Histomorphology of BCG infections in patients with severe combined immunodeficiency
52. Successful transplantation of soy bean agglutinin-fractioned, histoincompatible, maternal marrow in a patient with severe combined immunodeficiency and BCG infection
53. Disseminated BCG infection in severe combined immunodeficiency presenting with severe anaemia and associated with gross hypersplenism after bone marrow transplantation
54. Severe combined immunodeficiency: A retrospective singlecenter study of clinical presentation and outcome in 117 patients
55. Subcutaneous nodules as presenting sign of disseminated BCG infection in a SCID patient
56. Clinical picture of a generalized BCG vaccination tuberculosis as an expression of a progressive septic granulomatosis
57. Surgical pathology of the lung in chronic granulomatous disease
58. Chronic granulomatous disease: Clinical and functional studies in six cases
59. Disseminated BCG infection in a child with chronic granulomatous disease. A case report
60. BCG-infection in chronic granulomatous disease
61. Case report. Presumed disseminated BCG in a boy with chronic granulomatous disease of childhood
62. Generalized BCG infection, expression of multifactorial deficiency of intramacrophage bactericidal action. Anatomo-clinical study of 11 cases
63. Disseminated Bacillus Calmette-Guerin infection in a girl with hyperimmunoglobulin E syndrome
64. Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency
65. Infections caused by Mycobacterium avium complex in immunocompromised patients: Diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics
66. Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease
67. Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum
68. Clinical spectrum of X-linked hyper-IgM syndrome
69. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by hypomorphic NEMO mutations
70. Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome
71. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis
72. Granulomatous inflammation with combined immunodeficiency
73. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: Abnormal IL-12 regulation
74. Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene?
75. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
76. Detection of intracellular phosphorylated STAT-1 by flow cytometry
77. The IFN gamma receptor: A paradigm for cytokine receptor signaling
78. How cells respond to interferons
79. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma
80. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection
81. High levels of interferon gamma in the plasma of patients with complete interferon gamma-receptor deficiency
82. A point mutation in a domain of gamma interferon receptor I provokes severe immunodeflciency
83. Partial interferongamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection
84. Recurrent mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation
85. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion
86. Interferon-gamma and interleukin-12 pathway defects and human disease
87. Clinical consequences of defects in the IL-12-dependent interferongamma (IFN-gamma) pathway
88. Diagnosis and Management of inheritable disorders of interferon gammamediated immunity
89. Impaired Interferon gamma-mediated immunity and suceptibility to mycobacterial infection in childhood
90. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
91. Trinchieri G, Interleukin-12: A cytokine at the interface of inflammation and immunity
92. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
93. Mycobacterium fortuitum-chelonae complex infection in a child with complete Interleukin-12 receptor betal deficiency
94. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
95. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
96. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
97. Residual type I immunity in patients genetically deficient for interleukin-12 receptor beta1 (IL-12Rbetal). Evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T-cells
98. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis
99. Genetic predisposition to clinical tuberculosis: Bridging the gap between simple and complex inheritance